fluoxetine has been researched along with 6,7-dihydroxyflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, C; Hashimoto, K; Ma, M; Ren, Q; Wu, J; Yang, C; Yao, W; Zhang, JC | 1 |
| Amin, N; Botchway, BOA; Chen, Y; Fang, M; Hu, S; Hu, Z; Ma, Y; Ren, Q; Tan, X; Xie, S | 1 |
2 other study(ies) available for fluoxetine and 6,7-dihydroxyflavone
| Article | Year |
|---|---|
Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Azepines; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Dendritic Spines; Depression; Dexamethasone; Disease Models, Animal; Flavones; Fluoxetine; Gene Deletion; Hippocampus; Inflammation; Interleukin-1beta; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nucleus Accumbens; Phenotype; Receptor, trkB; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Optimized integration of fluoxetine and 7, 8-dihydroxyflavone as an efficient therapy for reversing depressive-like behavior in mice during the perimenopausal period.
Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Drug Therapy, Combination; Female; Flavones; Fluoxetine; Mice; Mice, Inbred C57BL; Ovariectomy; Perimenopause; Treatment Outcome | 2020 |